4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-024033
CEO and CFO bought 174,825 shares at $14.30 ($2,499,998)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-13 | Purchase : show line 1 in the form | +174,825 | $14.30 | $2,499,998 | 5,525,602 | D |
| Open-market purchases · 174,825 sh · avg $14.30 · $2,499,998 | ||||||
Loading xslF345X05/ownership.xml…